Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Nat Med. 2021 Oct;27(10):1850. doi: 10.1038/s41591-021-01569-2.
No abstract available

Publication types

  • Published Erratum